Frontlight ResearchEarly access
CompletedNo phase
Continuous Glucose Monitoring for Screening for Diabetes in Pregnancy
Key facts
- Who runs it
- The University of Texas Health Science Center, Houston
- Where
- Houston, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 1,628 people enrolled
- Started
- 7 Mar 2023
- Ended
- 16 Sept 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Group 1: one-hour GCT
- Group 2: CGM placement
- Record updated
- 4 December 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- 24-30 weeks gestation undergoing GDM screening
Who cannot take part
- History of bariatric surgery
- History of allergic reaction to any of CGM metals or adhesives in contact with the skin
- Known diagnosis of Type I and II DM
- Major fetal anomalies
- Unwilling to use CGM for GDM screening
- Incarcerated subjects
Where in United States
- The University of Texas Health Science Center at HoustonHouston, United States
About the trial
What the trial wants to find out
The purpose of this study is to evaluate whether Continuous glucose monitoring (CGM) for diagnosis of gestational diabetes mellitus (GDM) improves maternal and neonatal outcomes related to GDM and to evaluate whether CGM for GDM diagnosis reduces the health system costs for mother-infant dyads compared to usual care
The 2 groups in the trial
- one-hour Glucose tolerance test (GCT)Existing treatment, for comparison
Treatment: Group 1: one-hour GCT
- CGM screeningTreatment being tested
Treatment: Group 2: CGM placement
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Continuous Glucose Monitoring for Screening for Diabetes in Pregnancy:A Comparative Effectiveness Randomized Control Trial (PRECISE)
- Publications
- Continuous glucose monitoring in individuals undergoing gestational diabetes screening.American journal of obstetrics and gynecology, 2023
- Record updated
- 4 December 2025